These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22974752)

  • 1. Examination of ketamine-induced deficits in sensorimotor gating and spatial learning.
    Sabbagh JJ; Heaney CF; Bolton MM; Murtishaw AS; Kinney JW
    Physiol Behav; 2012 Oct; 107(3):355-63. PubMed ID: 22974752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in emotional learning and memory in an animal model of schizophrenia.
    Bolton MM; Heaney CF; Sabbagh JJ; Murtishaw AS; Magcalas CM; Kinney JW
    Behav Brain Res; 2012 Jul; 233(1):35-44. PubMed ID: 22569573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.
    Schreiber R; Vivian J; Hedley L; Szczepanski K; Secchi RL; Zuzow M; van Laarhoven S; Moreau JL; Martin JR; Sik A; Blokland A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):277-88. PubMed ID: 16989988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period.
    Uehara T; Sumiyoshi T; Hattori H; Itoh H; Matsuoka T; Iwakami N; Suzuki M; Kurachi M
    J Psychiatr Res; 2012 May; 46(5):622-9. PubMed ID: 22342346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
    Barr AM; Powell SB; Markou A; Geyer MA
    Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCγ-ERK signaling pathway in the developing brain.
    Huang L; Liu Y; Jin W; Ji X; Dong Z
    Brain Res; 2012 Oct; 1476():164-71. PubMed ID: 22985497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice.
    Featherstone RE; Liang Y; Saunders JA; Tatard-Leitman VM; Ehrlichman RS; Siegel SJ
    Neurobiol Dis; 2012 Sep; 47(3):338-46. PubMed ID: 22627142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine affects memory consolidation: differential effects in T-maze and passive avoidance paradigms in mice.
    Wang JH; Fu Y; Wilson FA; Ma YY
    Neuroscience; 2006 Jul; 140(3):993-1002. PubMed ID: 16600517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
    Roberts BM; Holden DE; Shaffer CL; Seymour PA; Menniti FS; Schmidt CJ; Williams GV; Castner SA
    Behav Brain Res; 2010 Sep; 212(1):41-8. PubMed ID: 20347881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity.
    Imre G; Fokkema DS; Den Boer JA; Ter Horst GJ
    Brain Res Bull; 2006 Apr; 69(3):338-45. PubMed ID: 16564431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modulatory effect of CA1 GABAb receptors on ketamine-induced spatial and non-spatial novelty detection deficits with respect to Ca(2+).
    Khanegheini A; Nasehi M; Zarrindast MR
    Neuroscience; 2015 Oct; 305():157-68. PubMed ID: 26254239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
    Lüttgen M; Elvander E; Madjid N; Ogren SO
    Neuropharmacology; 2005 May; 48(6):830-52. PubMed ID: 15829255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure.
    Enomoto T; Floresco SB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):668-75. PubMed ID: 19306904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia.
    Levkovitz Y; Levi U; Braw Y; Cohen H
    Brain Res; 2007 Jun; 1154():154-62. PubMed ID: 17488642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
    Horisawa T; Ishibashi T; Nishikawa H; Enomoto T; Toma S; Ishiyama T; Taiji M
    Behav Brain Res; 2011 Jun; 220(1):83-90. PubMed ID: 21277905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.
    Kos T; Popik P; Pietraszek M; Schäfer D; Danysz W; Dravolina O; Blokhina E; Galankin T; Bespalov AY
    Eur Neuropsychopharmacol; 2006 May; 16(4):297-310. PubMed ID: 16288851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S; Kuzmin A; Tai F; Ogren SO
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
    van der Staay FJ; Rutten K; Erb C; Blokland A
    Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.